The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Novartis stockpiles drugs in UK to ensure supply

Novartis production building
Novartis imports some 120 million packs of medicines into the UK each year. Keystone

Swiss pharmaceuticals giant Novartis says a no-deal Brexit could hurt patients and that it is stockpiling medicines in the UK to help ensure continuity of supply.

In a press release on Friday, it said that after the British parliament’s rejection of Prime Minister Theresa May’s Brexit deal, “the risk of UK exiting the EU without a deal is increased and this will be hugely impactful for patients, particularly around the supply and safety of medicines”. 

And it called for the British government to take action on medicines.

“It is vital that Government makes minimising disruption to the medicines supply the highest priority as it prepares for a potential hard or disorderly Brexit and ensures cooperation over medicines regulation in this event.”

The pharma giant said it is prioritising measures to ensure that patients in the UK can access medicines produced by Novartis and its Sandoz and Alcon affiliates. It imports some 120 million packs of medicines to the UK from Europe each year, according to the press release.

Novartis also urged the National Health Service and pharmacists in the UK to heed advice not to stockpile medicines, “so supply can be managed centrally, minimising the risk of medicine shortages across the UK”.

Novartis, maker of neurological, immunology and cancer drugs, employs around 1,500 people in the UK.

More


Popular Stories

Most Discussed

News

Corruption: Switzerland must provide better protection for whistleblowers

More

Switzerland must better protect whistleblowers, says OECD

This content was published on Switzerland must step up its anti-corruption efforts and provide better protection for whistleblowers while increasing fines for guilty firms, an OECD anti-bribery group says.

Read more: Switzerland must better protect whistleblowers, says OECD
Trust in news in Switzerland is on the rise again

More

Trust in Swiss news is rising, Reuters report shows

This content was published on Trust in the news has increased in Switzerland, according to the Reuters Institute Digital News Report 2025. Almost half (46%) of adults who took part in a recent survey said they generally trusted Swiss news, up 5%.

Read more: Trust in Swiss news is rising, Reuters report shows
TX Group discontinues print version of "20 Minuten"

More

20 Minuten: last Swiss free daily to stop being printed

This content was published on From the end of the year, there will no longer be a daily free newspaper in Switzerland: the TX Group is discontinuing the print version of "20 Minuten". Up to 80 full-time positions are to be cut in the editorial and publishing departments.

Read more: 20 Minuten: last Swiss free daily to stop being printed

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR